0001209191-15-079468.txt : 20151111
0001209191-15-079468.hdr.sgml : 20151111
20151110213819
ACCESSION NUMBER: 0001209191-15-079468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151106
FILED AS OF DATE: 20151110
DATE AS OF CHANGE: 20151110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTIME INC
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KINGSLEY ALFRED D
CENTRAL INDEX KEY: 0001229339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 151220937
MAIL ADDRESS:
STREET 1: 150 E 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-06
0
0000876343
BIOTIME INC
BTX
0001229339
KINGSLEY ALFRED D
150 E. 57TH STREET
NEW YORK
NY
10022
1
1
1
0
See Remarks
Common Shares, no par value
2015-11-06
4
S
0
100000
3.83
D
5938055
D
Common Shares, no par value
1506905
I
By Greenbelt Corp.
Common Shares, no par value
375351
I
By Greenway Partners, LP
Option to Purchase Common Shares
3.57
2020-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
3.11
2019-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
4.13
2018-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
4.60
2017-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
5.13
2016-06-30
Common Shares
50000
50000
D
The securities were sold in a private transaction. Mr. Kingsley plans to invest the sale proceeds in Ascendance Biotechnology, Inc., a new subsidiary of BioTime.
Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
12,500 options became exercisable on September 30, 2015 and the remaining 37,500 options will become exercisable in 3 equal quarterly installments based upon continued service on the board of directors.
12,500 options became exercisable on September 30, 2014; December 31, 2014; March 31, 2015; and June 30, 2015.
12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014.
12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013.
12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries.
/s/ Alfred D. Kingsley
2015-11-10